Search details
1.
Anti-PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC.
JCI Insight
; 7(3)2022 02 08.
Article
in English
| MEDLINE | ID: mdl-35132961
Results
1 -
1
de 1
1
Next >
>>